- Report
- October 2024
- 189 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- November 2024
- 363 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- August 2024
- 175 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Report
- September 2024
- 255 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- January 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- June 2024
- 80 Pages
United States
From €3859EUR$3,950USD£3,222GBP
- Report
- September 2024
Global
From €5276EUR$5,400USD£4,405GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 181 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- November 2024
- 281 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- January 2024
- 110 Pages
Global
From €5813EUR$5,950USD£4,853GBP
- Report
- September 2024
- 175 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Report
- June 2024
- 178 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- November 2024
- 194 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- January 2024
- 200 Pages
Global
From €3908EUR$4,000USD£3,263GBP
- Report
- January 2024
- 200 Pages
Global
From €3908EUR$4,000USD£3,263GBP
- Report
- September 2024
- 84 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- February 2024
- 190 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- October 2024
- 290 Pages
Global
From €4880EUR$4,995USD£4,074GBP
The Biodefense market is a sector of the biotechnology industry that focuses on the development of products and services to protect against biological threats. This includes the development of vaccines, diagnostics, and treatments for infectious diseases, as well as the development of countermeasures to protect against bioterrorism. Biodefense products are designed to protect against a wide range of biological agents, including bacteria, viruses, and toxins.
The Biodefense market is driven by the need to protect against the increasing threat of biological agents, as well as the need to develop treatments for existing and emerging infectious diseases. Governments, healthcare organizations, and private companies are investing in the development of biodefense products and services.
Some of the major companies in the Biodefense market include Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novavax, Pfizer, and Sanofi. These companies are developing a range of products and services to protect against biological threats, including vaccines, diagnostics, and treatments. Show Less Read more